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ABSTRACT
The binding of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) to Intracellular
Adhesion Molecule-1 (ICAM-1) is a major pathological mechanism in severe malaria including
cerebral malaria.The binding is mediated by PfEMP1-DBL2β domain. The study aimed to explore
there combinant protein of PfEMP1-DBL2β domain of P. falciparum isolated from Indonesia.
DNA was isolated from a severe malaria patient. The DBL2β domain was amplified using
Polymerase Chain Reaction (PCR) with specific primer and cloned into the pJET1 cloning vector.
The DBL2β recombinant protein was constructed from DBL2β-pJET1 clone using pET-30a
expression vector and expressed in Escherichia coli BL21-DE3. PCR colony and digestion of
plasmid clones using restriction enzymes were conducted to confirm cloning result, and the
expression of recombinant protein was analyzed using Sodium Dodecyl Sulfate-Polyacrylamide
Gel Electrophoresis (SDS-PAGE). The expression of DBL2β-PfEMP1 domain is higher in pellet
than in supernatant fraction. In conclusion, the DBL2β-PfEMP1 domain recombinant protein of P.
falciparum isolated from Indonesia expressed as a~ 66 kDa protein in full length.
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INTRODUCTION
Malaria is a major health problem worldwide,
the WHO (World Health Organization)
estimated million cases of malaria in 2017 with
435,000 death occurred worldwide. Of these,
about 6% case of malaria death occurred in the
South-East Asia Region (WHO, 2018)
including Indonesia. Almost half of the
Indonesian population lives in malaria-endemic
areas, especially in the Eastern part of
Indonesia such as Papua, Kalimantan, Nusa
Tenggara, Bangka Belitung, Maluku, and
Sulawesi provinces (The Ministry of Health the
Republic of Indonesia, 2016). The majority of
Plasmodium-causing malaria in Indonesia is
Plasmodium falciparum (63%) (WHO, 2018).
Severe malaria is majority caused by
infection of P. falciparum (WHO, 2019). P.
falciparum can infect all ages of red blood cells
and adhere to the vascular endothelium, called
cytoadherence. The cytoadherence plays a role
as a pathological mechanism in severe malaria
(Wassmer et al., 2015), it also serve as a
virulence determinant for complication in
malaria such as cerebral malaria (Milner et al.,
2015). The cytoadherence is mediated by P.
falciparum erythrocyte membrane protein 1
(PfEMP1) which is expressed by the parasite
and deposited on the surface of infected
erythrocytes (IE) (Sargeant et al., 2006). The
location of PfEMP1 on the surface membrane
makes it vulnerable to being recognized by the
immune system, but PfEMP1 has an antigenic
variation to evade immune recognition (Turner
et al., 2013).
The PfEMP1 proteins are encoded by the
var gene family, which consist of 60 different
variable genes, but only 1 type of var gene is
active in producing PfEMP1 in time (Scherf et
al., 2008). The large family of PfEMP1 protein
has high molecular weights from 200 to 350
kDa (Pasternak & Dzikowski, 2009). The
PfEMP1 has three basic structures, i.e., an
extracellular domain (ECD), a transmembrane
domain (TMD) and an intracellular acidic
terminal segment (ATS). The extracellular
domain consists of conserved N-terminal
segment (NTS), Duffy binding-like (DBL),
Cysteine-rich Interdomain Region (CIDR), and
constant 2 (C2). DBL domains have sub-
classes of α, β, γ, δ, ζ, ε, and x. CIDR is also
divided into classes of α, β, and γ (Flicka &
Chen, 2004). The TMD and ATS have a highly
conserved region of PfEMP1 (Hviid & Jensen,
2015).
The domain composition affects the
specific binding of PfEMP1 to host adhesion
receptors (Smith, 2014). PfEMP1 proteins bind
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to host adhesion receptors such as Cluster
Differentiation 36 (CD36), Intracellular
Adhesion Molecule-1 (ICAM-1), Chondroitin
Sulfate A (CSA), rosetting mediator or
autoagglutination and Immunoglobulin M
(IgM) and Endothelial Protein C receptor
(EPCR) (Smith, 2014; Bernabeu & Smith,
2017). Some studies showed that ICAM-1 is an
adhesion receptor associated with cerebral
malaria (Lucy et al., 2011) and DBLβ domain
as a ligand for ICAM-1, but not all DBLβ
domain of PfEMP1 bind to ICAM-1 (Smith et
al., 2000). The DBL2β domain from 3D7
isolate has specific binding to ICAM-1
(Oleinikov et al., 2009). The antibodies raised
by the full-length DBL2β (PF11_0521 allele)
recombinant proteins can block the binding of
DBL2β to ICAM-1. It is predicted that the full-
length domain resulted in the optimal function
of epitopes (Gullingsrud et al., 2013). The
previous study reported that the structure
prediction of DBL2β-PfEMP1 recombinant
protein isolated from Indonesia had significant
alignment with the domain of PfEMP1 that
bind to ICAM-1 (Sulistyaningsiha et al., 2018).
This study explored the expression of DBL2β
recombinant protein of P. falciparum isolated
from Indonesia to support the development of a
severe malaria vaccine based on PfEMP1
antigen.
METHODS
Patient and the ethical statement
The blood sample was collected from a man, 28
years old patient, diagnosed as clinically severe
malaria from Jember district, Indonesia in 2014. The
study was approved by The Ethical Committee of
Faculty of Medicine, University of Jember with
reference number 454/H25.1.11/KE/2014.
Construction and expression of DBL2β-PfEMP1
domain
DNA was isolated from blood of a severe malaria
patient using DNA isolation kit from Tiangen as
described by the manufacturer. Amplification of
DBL2β domain was conducted by PCR using Hot
Star Taq Master Mix PCR Kit and specific primers,
i.e. DBL2β_Fw5’-
CGGGATCCAGTGTGTTGAAGGACGTATGT-3’
which carrying a BamHI site and DBL2β_Rev 5’-
CCCTCGAGCCAAACATATATCTCTATAATCT
CC-3’, which carrying an XhoI site. The conditions
of PCR were as follow: pre-denaturation at 95°C  for
15 min, denaturation at 94°C for 45 sec, annealing
at 51°C  for 2 min, extension at 65°C for 2 min 30
secand final extension at 65°C for  10 min
(Sulistyaningsihb et al., 2018). The PCR product was
cloned into the pJET1 cloning vector. The DBL2β
recombinant protein was constructed from DBL2β-
pJET1 clone by digestion using BamHI (Promega)
and XhoI (Thermo Scientific) restriction enzymes
based on manufacturer's instruction, subcloned into
pET-30a expression vector and further transformed
into E.coli BL21-DE3 competent cells. The
transformant was selected on LB (Luria-Bertani)
agar plate containing Kanamycin. Confirmation of
cloning result was conducted by PCR colony,
digestion of plasmid clone, and sequencing.
The expression of recombinant protein was
performed by induction using Isopropyl β-D-1-
thiogalactopyranoside (IPTG) in a final
concentration of 0.1 mM, in room temperature.
There werethree differents duration of expression,
i.e. four hours, eight hours, and overnight. The
bacteria were harvested by centrifugation at 10,000
rpm for 1 min, and cell lysis was performed by
sonication. Pellet and supernatant were separated by
centrifugation at 12,000 rpm for 20 min.
Sodium Dodecyl Sulfate-Polyacrylamide Gel
Electrophoresis (SDS-PAGE) analysis
The recombinant protein was analyzed using SDS-
PAGE. The aliquot of either 100 µl supernatant or
100 µl pellet were added with 200 µl extraction
buffer, 200 µl sample buffer containing β-
mercaptoethanol and boiled at 90°C for 3 min. As
much as 10µl protein were loaded in each well of
SDS-PAGE. The running of the lower gel was
conducted at 50 V for 1 hour and the upper gel was
run at 100 V for 3 hours. The gel was visualized by
using comassie brilliant blue (CBB).
RESULTS AND DISCUSSION
Confirmation of cloning
Five colonies were picked up to confirm the
cloning process by PCR colony method using
DBL2β specific primer. PCR product showed
the presence of a single bandwith the molecular
weight of approximately 1,700 bp. The second
confirmation was performed by digestion of
plasmid clone using BamHI and XhoI
restriction enzymes. The result showed two
bands of approximately 5,400 bp and 1,700 bp
(Figure 1). The sequencing of the plasmid
clone followed by alignment analysis
confirmed that the sequence was the DBL2β
sequence.
The previous study conducted by
Sulistyaningsiha et al., 2018 reported that the
DBL2β domain of vargene of P. falciparum
isolated from Indonesia had 1,674 nucleotides
(Sulistyaningsiha et al., 2018), as confirmed by
sequencing.
Expression of recombinant proteins
The SDS-PAGE analysis showed that the
recombinant protein of DBL2β-PfEMP1
domain had a molecular weight of ~66.2 kDa
(Figure 2). It was slightly different from the
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previous studies conducted by Sulistyaningsiha
et al., 2018 that the DBL2β-PfEMP1 protein
predicted to have a molecular weight of 64.69
kDa (Sulistyaningsiha et al., 2018), while
another study reported that DBL2β domain of
PfEMP1 had a molecular weight of 74 kDa
(Flickb et al., 2004).
In this study, expression of the DBL2β-
PfEMP1 recombinant protein was analyzed in
two fractions, i.e., in pellet as insoluble protein
and supernatant as a soluble protein. The SDS-
PAGE analysis showed that the band resulted
from the pellet fraction is thicker than from the
supernatant fraction, meaning that the DBL2β-
PfEMP1 recombinant protein more expressed
as insoluble protein. The previous study
predicted that the DBL2β-C2 domain is an
insoluble protein with 30% solubility.
The previous study also reported the
solubility prediction of other PfEMP1 domains
as follow: ATS (56.7%) > CIDRIα (46.8%) >
CIDR2β (42.9%) > DBL2-4γ (31.7%) >
DBLIα (24.9%) > DBL2-7ε (23.1%) > DBL2-
5δ (14.8%). The length of the domain does not
affect solubility (Ahuja et al., 2006). Several
factors have been suggested that influence the
solubility of recombinant protein including
culture pH, temperature, and amino acid
composition of the protein. The solubility of
the protein related to the correctness of the
folding process that occurs during a post-
translational process (Vaillancourt, 2003),
when the folding is incorrect the protein tend to
accumulate as inclusion bodies.
This study used 0.1 mM IPTG to induce
expression. The duration of induction time
affected the amount of expression of the
recombinant protein, the longer the induction
time, the more the expressed recombinant
protein. The protein solubility can be improved
by changing the induction time at post-log
phase. At the stage where the bacterium growth
slowly, the biosynthesis process also runs
slowly. The low speed of the synthesis process
influences the peptides assembly efficiently
into the correct structure that results in the
soluble fraction. This optimation is an
important key to successfully express the A/T
high content protein (Flickb et al., 2004). P.
falciparum has 80% A/T content that making
expression is inhibited (Horrock et al., 2000).
Figure 1. Confirmation of cloning product (pET30a_DBL2β)by digestion using BamH1 and XhoI
restriction enzymes in 1% electrophoresis gel. Line 1: 1 kb DNA ladder; Line 2: pET-
30a plasmid after double digestions; Line 3: the DBL2β fragment resulted from
amplification using a specific primerof DBL2β-PfEMP1; Line 4: the pET30a_DBL2β
clone after double digestionsusing BamH1 and XhoIenzymes.The digestion
ofpET30a_DBL2β clone resulted in two bands: 5,400 bp (a) and 1,700 bp (b).
70 The Expression of The PfEMP1-DBL2β …           (Sulistyaningsih, et al)
Figure 2. The SDS-PAGE analysis of expression of the DBL2β-PfEMP1 recombinant proteins
induced by 0.1 mM IPTG in both insoluble and soluble fractions in different induction
time. M: protein marker; Line 1 and 2: E. coli (control) cells ininsolubleand soluble
fractions; Line3  and 4: 4 hours induction of the recombinant proteins in insoluble and
soluble fractions; Line 5 and 6: 8 hours induction of the recombinant proteins in
insoluble and soluble fractions; Line 7 and 8: overnight induction of the recombinant
proteins in insoluble and soluble fractions. The black arrow showed the band of the
DBL2β-PfEMP1 recombinant protein.
Several studies reported that the
recombinant protein of multiple domains of
PfEMP1 is expressed as the truncated form,
due to characteristics of P. falciparum genome
which has lysine and arginine repeats causing
early termination in the translation process
(Flickb et al., 2004). In the present study, the
expression of the DBL2β-PfEMP1
recombinant protein is a full length, with the
molecular weight of ~66 kDa. The full-length
domain is important for optimal function of
epitopes and a broad surface of interaction with
ICAM-1 (Gullingsrud et al., 2013). The protein
immunogenicity is affected by molecular
weight of over 10kDa and amino acid residues
composition with positive charges (arginine,
lysine, histidine) (Farber et al., 2007).
Prediction of DBL2β-PfEMP1 domain
protein by Expasy tool programm showed that
the protein had a the oretical pI of 8.82 amino
acid residues with positive charges
(arginine+lysine) and negaive charges
(aspartate+glutamate) (Sulistyaningsiha et al.,
2018).
Protein functional studies for potentially
useful vaccine and drug candidates need a
soluble protein (Flickb et al., 2004).
Previous studies reported that the DBLβ
domain of PfEMP1 is a ligand for ICAM-1
(Smith et al., 2000), but not all DBLβ domain
of PfEMP1 bind to ICAM-1 Only 6/24 of the
DBLβ domain of IT4 genome bound to ICAM-
1 (Dasein et al., 2007) and only 1/18 DBLβ
domain of  PF11_0521 allele, particularly the
DBL2β domain, of 3D7 genome has avidity to
bind ICAM-1 (Oleinikov et al., 2009). Based
on our previous study, the DBL2β domain
protein from Indonesian P. falciparum isolate
had significant alignment with the DBLβ of
PF11_0521 allele and high similarity to EBA-
175 Region of P. falciparum protein which acts
as a cell invasion molecule. The similarity of
the structure is related to the similarity of
functions (Lennart et al., 2017). The binding
ability to ICAM1 depends on residues have an
important role in structure or direct contact
with the ligand (Oleinikov et al., 2009). The
previous study indicated that the number of
amino acids of the DBL2β-PfEMP1 domain
recombinant protein was 558 amino acids
(Sulistyaningsihb et al., 2018), while another
study showed the full length of DBL2β domain
of PF11_0521 PfEMP1 protein from 3D7
isolate consist of 522 amino acids (Oleinikov et
al., 2009). The prediction of residue which
functions as a binding site were at 84, 87, 88,
91, 92, 95, 99, 196, 199, 200, 203, 206 and
suspected to have a role as an adhesion
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molecule (Sulistyaningsiha et al., 2018).
Several designs of the interaction model
between DBL2β and ICAM-1 from the recent
study suggested that N-terminal subdomain
involved in ICAM-1 binding activity (Wassmer
et al., 2015).
It is necessary to generalize isolates across
geographically diverse to provide an
understanding mechanism of disease andto
design an anti-adhesion structure as a new
treatment (Smith, 2014). Our study has
explored the PfEMP1 from Indonesian P.
falciparum isolates, especially provided the
DBL2-PfEMP1 recombinant protein which has
implication for severe malaria. The full-length
expression of the recombinant protein, making
it potential as peptide-based vaccine design.
Further study is needed to overcome the
limitation of the functional recombinant protein
to design a peptide-based vaccine.
CONCLUSION
The data showed that PfEMP1-DBL2β domain
recombinant protein of Plasmodium falciparum
isolated from Indonesia was a ~66.2 kDa
protein in full length and more expressed in
pellet than a supernatant fraction or the protein
has low solubility. Further study about
optimization of solubility and protein
antigenicity test should be needed to support
the development of a severe malaria vaccine
based on PfEMP1 antigen.
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